RENAISSANCE TECHNOLOGIES LLC

Position in DYAI — Dyadic International Inc

CIK 1037389 NEW YORK, NY

Position in DYAI

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$70,907

+$3,942 QoQ

Shares Held

78,786

-3.5% QoQ

Ownership

0.216%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#11

of 39 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. DYAI ranks #282 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$70,907	78,786	-3.5%	Shares	Sole	2026-08-13
2026-03-31	$66,965	81,665	-44.7%	Shares	Sole	2026-05-14
2025-12-31	$138,758	147,615	-10.6%	Shares	Sole	2026-02-12
2025-09-30	$194,818	165,100	+246.8%	Shares	Sole	2025-11-13
2025-06-30	$47,128	47,605	+53.7%	Shares	Sole	2025-08-13
2025-03-31	$41,817	30,976	+24.4%	Shares	Sole	2025-05-14
2024-12-31	$43,575	24,900	+8.3%	Shares	Sole	2025-02-13
2024-09-30	$23,920	23,000	+8.5%	Shares	Sole	2024-11-13
2024-06-30	$31,376	21,200	+25.4%	Shares	Sole	2024-08-09
2024-03-31	$28,223	16,900	+9.7%	Shares	Sole	2024-05-13
2023-12-31	$24,794	15,400	+40.0%	Shares	Sole	2024-02-13
2023-09-30	$21,120	11,000	-85.6%	Shares	Sole	2023-11-14
2021-06-30	$273,558	76,200	+98.4%	Shares	Sole	2021-08-13
2021-03-31	$210,816	38,400	+40.5%	Shares	Sole	2021-05-13
2020-12-31	$147,024	27,328	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.